Skip to main content

. 1932 Oct 8;2(3744):657–662. doi: 10.1136/bmj.2.3744.657

Remarks on THE SERUM TREATMENT OF PNEUMONIA ^*

Russell L Cecil

PMCID: PMC2521708 PMID: 20777090

657

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Armstrong R. R., Johnson R. S. HOMOLOGOUS ANTIPNEUMOCOCCAL SERUMS IN THE TREATMENT OF LOBAR PNEUMONIA. Br Med J. 1931 May 30;1(3673):931–936. doi: 10.1136/bmj.1.3673.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cole R. THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA. J Exp Med. 1917 Oct 1;26(4):453–475. doi: 10.1084/jem.26.4.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cooper G., Edwards M., Rosenstein C. THE SEPARATION OF TYPES AMONG THE PNEUMOCOCCI HITHERTO CALLED GROUP IV AND THE DEVELOPMENT OF THERAPEUTIC ANTISERUMS FOR THESE TYPES. J Exp Med. 1929 Feb 28;49(3):461–474. doi: 10.1084/jem.49.3.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cooper G., Rosenstein C., Walter A., Peizer L. THE FURTHER SEPARATION OF TYPES AMONG THE PNEUMOCOCCI HITHERTO INCLUDED IN GROUP IV AND THE DEVELOPMENT OF THERAPEUTIC ANTISERA FOR THESE TYPES. J Exp Med. 1932 Mar 31;55(4):531–554. doi: 10.1084/jem.55.4.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dochez A. R. THE PRESENCE OF PROTECTIVE SUBSTANCES IN HUMAN SERUM DURING LOBAR PNEUMONIA. J Exp Med. 1912 Nov 1;16(5):665–679. doi: 10.1084/jem.16.5.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
Gay F. P., Chickering H. T. CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM BY MEANS OF SPECIFIC PRECIPITATION. J Exp Med. 1915 Apr 1;21(4):389–400. doi: 10.1084/jem.21.4.389. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES